RADICAVA Trademark

Trademark Overview

On Tuesday, August 9, 2016, a trademark application was filed for RADICAVA with the United States Patent and Trademark Office. The USPTO has given the RADICAVA trademark a serial number of 87132086. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, August 8, 2024. This trademark is owned by Mitsubishi Tanabe Pharma Corporation. The RADICAVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system diseases; Pharmaceutical preparations for protection against free radicals; Pharmaceutical preparations for removing free radicals from the human bodies; Neuroprotective medicines; Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)
radicava

General Information

Serial Number87132086
Word MarkRADICAVA
Filing DateTuesday, August 9, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, August 8, 2024
Registration Number5387607
Registration DateTuesday, January 23, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 1, 2016

Trademark Statements

Description of MarkThe mark consists of the stylized term "RADICAVA" above six curved lines each formed by dots and each of increasing lengths.
Goods and ServicesPharmaceutical preparations for the treatment of central nervous system diseases; Pharmaceutical preparations for protection against free radicals; Pharmaceutical preparations for removing free radicals from the human bodies; Neuroprotective medicines; Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 12, 2016
Primary Code005
First Use Anywhere DateTuesday, July 18, 2017
First Use In Commerce DateTuesday, July 18, 2017

Trademark Owner History

Party NameMitsubishi Tanabe Pharma Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka 541-8505
JP
Party NameMitsubishi Tanabe Pharma Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka 541-8505
JP
Party NameMitsubishi Tanabe Pharma Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka 541-8505
JP

Trademark Events

Event DateEvent Description
Monday, August 29, 2016ASSIGNED TO EXAMINER
Tuesday, September 27, 2016ASSIGNED TO LIE
Friday, August 12, 2016NEW APPLICATION ENTERED
Friday, August 12, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 13, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, August 30, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 30, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, August 30, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 30, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, September 14, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 7, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, September 27, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 12, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 1, 2016PUBLISHED FOR OPPOSITION
Tuesday, November 1, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 22, 2017SOU TEAS EXTENSION RECEIVED
Thursday, June 22, 2017SOU EXTENSION 1 FILED
Thursday, June 22, 2017SOU EXTENSION 1 GRANTED
Saturday, June 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 21, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 23, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, December 7, 2017SOU TEAS EXTENSION RECEIVED
Thursday, December 7, 2017SOU EXTENSION 2 FILED
Thursday, December 7, 2017USE AMENDMENT FILED
Monday, December 11, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 11, 2017SOU EXTENSION 2 GRANTED
Monday, December 11, 2017STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 20, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 6, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 8, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, August 8, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, January 19, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, January 23, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

radicava pharmaceutical preparations radicals free treatment neuroprotective bodies medicines amyotrophic sclerosis